首页 > 最新文献

Indian journal of cancer最新文献

英文 中文
Rare complication of chylous ascites following surgery and radiotherapy in endometrial carcinoma managed by diet modification: Case report. 饮食调整治疗子宫内膜癌手术放疗后乳糜腹水的罕见并发症:1例报告。
IF 0.9 4区 医学 Q4 ONCOLOGY Pub Date : 2025-01-01 Epub Date: 2025-05-16 DOI: 10.4103/ijc.ijc_503_21
Rujuta N Hantodkar, Bijal Patel, Pariseema S Dave, Neil Palkhiwala

Abstract: Chylous ascites is an uncommon complication seen in gynecological malignancies. The incidence of postoperative chylous ascites in gynecological malignancies is 0.17%. It is the extravasation of milky chyle into the peritoneal cavity due to lymphatic obstruction or injury and is diagnosed by the detection of triglyceride levels greater than 200 mg/dl in ascitic fluid. The site of leakage can be determined by lymphangiography or lymphoscintigraphy. The majority of the cases of chylous ascites can be treated by conservative methods, such as a dietary modification to a low-fat high-protein diet, bowel rest, total parenteral nutrition, medications, and large-volume paracentesis. If these measures fail, surgical modalities such as laparotomy or peritoneovenous shunting are employed. In our case, the patient was successfully managed on dietary modification alone. This case report emphasizes the importance of conservative management for chylous ascites following surgery and radiotherapy in endometrial carcinoma.

摘要:乳糜腹水是妇科恶性肿瘤中一种罕见的并发症。妇科恶性肿瘤术后乳糜腹水发生率为0.17%。它是由于淋巴阻塞或损伤导致乳白色乳糜外溢进入腹腔,通过检测腹水中甘油三酯水平大于200mg /dl来诊断。渗漏部位可通过淋巴管造影或淋巴显像确定。大多数乳糜腹水病例可通过保守方法治疗,如饮食调整为低脂高蛋白饮食、肠道休息、全肠外营养、药物治疗和大容量穿刺。如果这些措施失败,手术方式,如剖腹手术或腹膜静脉分流。在我们的病例中,仅通过饮食调整就成功地控制了患者。本病例报告强调了子宫内膜癌手术和放疗后乳糜腹水保守治疗的重要性。
{"title":"Rare complication of chylous ascites following surgery and radiotherapy in endometrial carcinoma managed by diet modification: Case report.","authors":"Rujuta N Hantodkar, Bijal Patel, Pariseema S Dave, Neil Palkhiwala","doi":"10.4103/ijc.ijc_503_21","DOIUrl":"10.4103/ijc.ijc_503_21","url":null,"abstract":"<p><strong>Abstract: </strong>Chylous ascites is an uncommon complication seen in gynecological malignancies. The incidence of postoperative chylous ascites in gynecological malignancies is 0.17%. It is the extravasation of milky chyle into the peritoneal cavity due to lymphatic obstruction or injury and is diagnosed by the detection of triglyceride levels greater than 200 mg/dl in ascitic fluid. The site of leakage can be determined by lymphangiography or lymphoscintigraphy. The majority of the cases of chylous ascites can be treated by conservative methods, such as a dietary modification to a low-fat high-protein diet, bowel rest, total parenteral nutrition, medications, and large-volume paracentesis. If these measures fail, surgical modalities such as laparotomy or peritoneovenous shunting are employed. In our case, the patient was successfully managed on dietary modification alone. This case report emphasizes the importance of conservative management for chylous ascites following surgery and radiotherapy in endometrial carcinoma.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 1","pages":"153-155"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144077889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High plasma prolactin is associated with PRL-R and predicts poor prognosis in Chinese postmenopausal women with breast cancer. 中国绝经后乳腺癌患者血浆催乳素升高与PRL-R相关并预示预后不良。
IF 0.9 4区 医学 Q4 ONCOLOGY Pub Date : 2025-01-01 Epub Date: 2025-05-16 DOI: 10.4103/ijc.ijc_1018_21
Lifang He, Xiaolong Jin, Jundong Wu, Xiaolong Wei, Guangsheng Huang, Yingsong Hong, Yaoquan Li, Peide Liang, Wen-He Huang

Background: Prolactin (PRL) plays an important role in mammary epithelial cell development and lactation. Increased levels of PRL are observed in human breast cancer, but the underlying mechanism and prognostic significance of PRL are still controversial. In this study, we sought to determine the significance of PRL in Chinese postmenopausal women with breast cancer.

Methods: Plasma PRL levels in 326 healthy individuals and 333 postmenopausal breast cancer patients were analyzed. Immunohistochemical staining of cytoplasmic prolactin receptor (PRL-R) was performed. Moreover, the relationships between plasma PRL and clinicopathological parameters as well as survival in breast cancer patients were evaluated.

Results: We found that high plasma levels of PRL was more common in breast cancer patients than in healthy individuals. We also observed that high level of PRL was associated with adverse prognostic factors, such as larger tumor size, more lymph node metastasis, advanced tumor stage, negative estrogen receptor (ER) expression, and negative progesterone receptor (PR) expression of breast cancer. Kaplan-Meier analysis showed that high plasma level of PRL correlated with poor disease-free and overall survival, while Cox regression models demonstrated that high plasma level of PRL was an independent prognostic marker for disease-free survival. The rate of PRL-R positivity among those with high plasma PRL was significantly higher than that of patients with low PRL (P < 0.05).

Conclusion: The plasma PRL level and PRL-R expression in tumor tissue may be prognostic for Chinese postmenopausal women with breast cancer. The inhibition of PRL and PRL-R signaling is a potential therapeutic approach for endocrine therapy in breast cancer.

背景:催乳素(PRL)在乳腺上皮细胞发育和泌乳过程中起重要作用。在人类乳腺癌中观察到PRL水平升高,但PRL的潜在机制和预后意义仍存在争议。在这项研究中,我们试图确定PRL在中国绝经后乳腺癌妇女中的意义。方法:对326例健康人及333例绝经后乳腺癌患者血浆PRL水平进行分析。细胞质催乳素受体(PRL-R)免疫组化染色。此外,我们还评估了血浆PRL与乳腺癌患者临床病理参数及生存率的关系。结果:我们发现高血浆PRL水平在乳腺癌患者中比在健康人中更常见。我们还观察到,高水平的PRL与乳腺癌的不良预后因素有关,如肿瘤大小较大、淋巴结转移较多、肿瘤分期较晚、雌激素受体(ER)负表达、孕激素受体(PR)负表达。Kaplan-Meier分析显示血浆PRL水平高与无病生存期和总生存期差相关,Cox回归模型显示血浆PRL水平高是无病生存期的独立预后指标。血浆PRL高组PRL- r阳性率显著高于血浆PRL低组(P < 0.05)。结论:血浆PRL水平及肿瘤组织中PRL- r表达可能与绝经后乳腺癌预后有关。抑制PRL和PRL- r信号是一种潜在的乳腺癌内分泌治疗方法。
{"title":"High plasma prolactin is associated with PRL-R and predicts poor prognosis in Chinese postmenopausal women with breast cancer.","authors":"Lifang He, Xiaolong Jin, Jundong Wu, Xiaolong Wei, Guangsheng Huang, Yingsong Hong, Yaoquan Li, Peide Liang, Wen-He Huang","doi":"10.4103/ijc.ijc_1018_21","DOIUrl":"10.4103/ijc.ijc_1018_21","url":null,"abstract":"<p><strong>Background: </strong>Prolactin (PRL) plays an important role in mammary epithelial cell development and lactation. Increased levels of PRL are observed in human breast cancer, but the underlying mechanism and prognostic significance of PRL are still controversial. In this study, we sought to determine the significance of PRL in Chinese postmenopausal women with breast cancer.</p><p><strong>Methods: </strong>Plasma PRL levels in 326 healthy individuals and 333 postmenopausal breast cancer patients were analyzed. Immunohistochemical staining of cytoplasmic prolactin receptor (PRL-R) was performed. Moreover, the relationships between plasma PRL and clinicopathological parameters as well as survival in breast cancer patients were evaluated.</p><p><strong>Results: </strong>We found that high plasma levels of PRL was more common in breast cancer patients than in healthy individuals. We also observed that high level of PRL was associated with adverse prognostic factors, such as larger tumor size, more lymph node metastasis, advanced tumor stage, negative estrogen receptor (ER) expression, and negative progesterone receptor (PR) expression of breast cancer. Kaplan-Meier analysis showed that high plasma level of PRL correlated with poor disease-free and overall survival, while Cox regression models demonstrated that high plasma level of PRL was an independent prognostic marker for disease-free survival. The rate of PRL-R positivity among those with high plasma PRL was significantly higher than that of patients with low PRL (P < 0.05).</p><p><strong>Conclusion: </strong>The plasma PRL level and PRL-R expression in tumor tissue may be prognostic for Chinese postmenopausal women with breast cancer. The inhibition of PRL and PRL-R signaling is a potential therapeutic approach for endocrine therapy in breast cancer.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 1","pages":"37-44"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144077661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CD3 negative T-ALL - A case study of three cases and review of the literature. CD3阴性T-ALL - 3例病例分析及文献复习。
IF 0.9 4区 医学 Q4 ONCOLOGY Pub Date : 2025-01-01 Epub Date: 2025-05-16 DOI: 10.4103/ijc.ijc_505_21
Shashi Bansal, Simran Gilhotra, Upendra Sharma, Abhishek Purohit

Abstract: T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) is a neoplasm of lymphoblasts that is usually TdT-positive and variably expresses CD1a, CD2, cytoplasmic CD3 (cytoCD3), CD4, CD5, CD7, and CD8. Acute undifferentiated leukemia (AUL) is a rare entity and is defined by the expression of not more than one membrane marker for any given lineage. Blasts express HLA-DR, CD34, and/or CD38 and may be positive for terminal deoxynucleotidyl transferase (TdT). Mixed-phenotype acute leukemia (MPAL) is a hematologic malignancy with immunophenotypic co-expression of markers from at least two cell lineages. In this case series of acute leukemia, we emphasize on key diagnostic or biological points of acute leukemia of ambiguous lineage versus T-ALL and provide a relevant literature review. A diagnosis of AUL can be debatable for our cases; however, the positivity of CD5 and CD7 (bright) ruled out AUL. Although cyCD3 is a T-cell lineage-specific marker of T-ALL, its negativity does not always rule out the diagnosis as several cases have been reported with a negative cyCD3, as reported in our cases.

摘要:t细胞急性淋巴细胞白血病/淋巴瘤(T-ALL/LBL)是一种淋巴母细胞肿瘤,通常为tdt阳性,表达CD1a、CD2、细胞质CD3 (cytoCD3)、CD4、CD5、CD7和CD8。急性未分化白血病(Acute undifferentiated leukemia, AUL)是一种罕见的疾病,其定义是在任何谱系中不多于一种膜标记物的表达。母细胞表达HLA-DR、CD34和/或CD38,并可能对末端脱氧核苷酸转移酶(TdT)呈阳性。混合表型急性白血病(MPAL)是一种血液系统恶性肿瘤与免疫表型共表达标记从至少两个细胞系。在本病例系列的急性白血病中,我们强调了谱系不明确的急性白血病与T-ALL的诊断或生物学要点,并提供了相关的文献综述。对于我们的病例,AUL的诊断是有争议的;然而,CD5和CD7阳性(亮)排除了AUL。虽然cyCD3是T-ALL的t细胞谱系特异性标记物,但其阴性并不总是排除诊断,因为据报道有几例cyCD3阴性,正如我们的病例所报道的那样。
{"title":"CD3 negative T-ALL - A case study of three cases and review of the literature.","authors":"Shashi Bansal, Simran Gilhotra, Upendra Sharma, Abhishek Purohit","doi":"10.4103/ijc.ijc_505_21","DOIUrl":"10.4103/ijc.ijc_505_21","url":null,"abstract":"<p><strong>Abstract: </strong>T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) is a neoplasm of lymphoblasts that is usually TdT-positive and variably expresses CD1a, CD2, cytoplasmic CD3 (cytoCD3), CD4, CD5, CD7, and CD8. Acute undifferentiated leukemia (AUL) is a rare entity and is defined by the expression of not more than one membrane marker for any given lineage. Blasts express HLA-DR, CD34, and/or CD38 and may be positive for terminal deoxynucleotidyl transferase (TdT). Mixed-phenotype acute leukemia (MPAL) is a hematologic malignancy with immunophenotypic co-expression of markers from at least two cell lineages. In this case series of acute leukemia, we emphasize on key diagnostic or biological points of acute leukemia of ambiguous lineage versus T-ALL and provide a relevant literature review. A diagnosis of AUL can be debatable for our cases; however, the positivity of CD5 and CD7 (bright) ruled out AUL. Although cyCD3 is a T-cell lineage-specific marker of T-ALL, its negativity does not always rule out the diagnosis as several cases have been reported with a negative cyCD3, as reported in our cases.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 1","pages":"156-161"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144077615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychosocial issues faced by children with cancer: Lessons learnt from a tertiary care center in South India. 癌症儿童面临的社会心理问题:从南印度三级保健中心吸取的经验教训。
IF 0.9 4区 医学 Q4 ONCOLOGY Pub Date : 2025-01-01 Epub Date: 2025-05-16 DOI: 10.4103/ijc.ijc_893_21
Sheena Shajan, Hema N Srinivasan, Leenu L Joseph, Deepthi Boddu, Rikki R John, Leni G Mathew, Sidharth Totadri

Background: Psychosocial issues adversely impact children with cancer but are seldom addressed.

Materials and methods: Children with cancer who were consecutively referred to the pediatric psycho-oncologist from June 2016 to September 2018 were included in a retrospective study. Psychosocial issues were categorized as disease related (DR), treatment related (TR), interpersonal related (IPR), and academic related (AR). The interventions provided were classified as counseling, prolonged psychotherapy, and referral to a child psychiatrist for pharmacologic therapy.

Results: The mean age of the 212 children included in the study was 10.7 ± 4.2 years, and the male to female ratio was 1.8:1. Of the 212 children, AR, TR, DR, and IPR concerns were identified in 93 (44%), 61 (29%), 41 (19%), and three (1%) patients, respectively. Fourteen of the 212 (7%) patients had concerns spanning all four domains. Thirty-six (48%) of the 56 children aged ≤7 years were identified to have TR issues. Of the 99 children aged ≥13 years, 65 (61%) demonstrated AR issues.

Conclusions: Children with cancer experience several psychosocial issues. They can be classified into specific clusters that differ across different age groups. The majority of patients with psychosocial concerns can be managed with psychotherapy.

背景:心理社会问题对癌症儿童有不利影响,但很少得到解决。材料与方法:将2016年6月至2018年9月期间连续转诊至儿科心理肿瘤科的癌症患儿纳入回顾性研究。心理社会问题分为疾病相关(DR)、治疗相关(TR)、人际相关(IPR)和学术相关(AR)。提供的干预措施分为咨询、长期心理治疗和转介给儿童精神病学家进行药物治疗。结果:纳入研究的212例患儿平均年龄为10.7±4.2岁,男女比例为1.8:1。在212名儿童中,分别有93名(44%)、61名(29%)、41名(19%)和3名(1%)患者存在AR、TR、DR和IPR问题。212例患者中有14例(7%)存在所有四个领域的担忧。56名年龄≤7岁的儿童中有36名(48%)被确定有TR问题。在99名年龄≥13岁的儿童中,65名(61%)出现AR问题。结论:患有癌症的儿童会经历一些社会心理问题。他们可以在不同的年龄组中被分为不同的特定组。大多数有心理社会问题的患者可以通过心理治疗来控制。
{"title":"Psychosocial issues faced by children with cancer: Lessons learnt from a tertiary care center in South India.","authors":"Sheena Shajan, Hema N Srinivasan, Leenu L Joseph, Deepthi Boddu, Rikki R John, Leni G Mathew, Sidharth Totadri","doi":"10.4103/ijc.ijc_893_21","DOIUrl":"10.4103/ijc.ijc_893_21","url":null,"abstract":"<p><strong>Background: </strong>Psychosocial issues adversely impact children with cancer but are seldom addressed.</p><p><strong>Materials and methods: </strong>Children with cancer who were consecutively referred to the pediatric psycho-oncologist from June 2016 to September 2018 were included in a retrospective study. Psychosocial issues were categorized as disease related (DR), treatment related (TR), interpersonal related (IPR), and academic related (AR). The interventions provided were classified as counseling, prolonged psychotherapy, and referral to a child psychiatrist for pharmacologic therapy.</p><p><strong>Results: </strong>The mean age of the 212 children included in the study was 10.7 ± 4.2 years, and the male to female ratio was 1.8:1. Of the 212 children, AR, TR, DR, and IPR concerns were identified in 93 (44%), 61 (29%), 41 (19%), and three (1%) patients, respectively. Fourteen of the 212 (7%) patients had concerns spanning all four domains. Thirty-six (48%) of the 56 children aged ≤7 years were identified to have TR issues. Of the 99 children aged ≥13 years, 65 (61%) demonstrated AR issues.</p><p><strong>Conclusions: </strong>Children with cancer experience several psychosocial issues. They can be classified into specific clusters that differ across different age groups. The majority of patients with psychosocial concerns can be managed with psychotherapy.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 1","pages":"11-16"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144077882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
News in oncology. 肿瘤学新闻。
IF 0.9 4区 医学 Q4 ONCOLOGY Pub Date : 2025-01-01 Epub Date: 2025-05-16 DOI: 10.4103/ijc.ijc_3_25
Prahlad H Yathiraj, Anuja Raniwala, Ritika Harjani Hinduja
{"title":"News in oncology.","authors":"Prahlad H Yathiraj, Anuja Raniwala, Ritika Harjani Hinduja","doi":"10.4103/ijc.ijc_3_25","DOIUrl":"10.4103/ijc.ijc_3_25","url":null,"abstract":"","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 1","pages":"175-176"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case report of Ewing's sarcoma of mandible - an unforeseen quandary. 下颌骨尤文氏肉瘤1例报告——一个无法预料的困境。
IF 0.9 4区 医学 Q4 ONCOLOGY Pub Date : 2025-01-01 Epub Date: 2025-05-16 DOI: 10.4103/ijc.ijc_652_21
Pritesh Ruparelia, Oshin Verma, Navneet Gill, Kosha Ruparelia

Abstract: Ewing's sarcoma (ES) is a rare sarcoma of bone and soft tissue that uncommonly involves head and neck. Accurate diagnosis of ES family of tumors is crucial for appropriate clinical management of patients. The present case demonstrates the importance of advanced imaging technologies to aid in proper diagnosis of ES.

摘要:尤文氏肉瘤(Ewing’s sarcoma, ES)是一种罕见的骨和软组织肉瘤,通常累及头颈部。ES家族肿瘤的准确诊断对患者的临床治疗至关重要。本病例显示了先进的成像技术对帮助正确诊断ES的重要性。
{"title":"Case report of Ewing's sarcoma of mandible - an unforeseen quandary.","authors":"Pritesh Ruparelia, Oshin Verma, Navneet Gill, Kosha Ruparelia","doi":"10.4103/ijc.ijc_652_21","DOIUrl":"10.4103/ijc.ijc_652_21","url":null,"abstract":"<p><strong>Abstract: </strong>Ewing's sarcoma (ES) is a rare sarcoma of bone and soft tissue that uncommonly involves head and neck. Accurate diagnosis of ES family of tumors is crucial for appropriate clinical management of patients. The present case demonstrates the importance of advanced imaging technologies to aid in proper diagnosis of ES.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 1","pages":"169-172"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144077429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and pathological characteristics and treatment of gastric cancer during pregnancy. 妊娠期胃癌的临床病理特点及治疗。
IF 0.9 4区 医学 Q4 ONCOLOGY Pub Date : 2025-01-01 Epub Date: 2025-05-16 DOI: 10.4103/ijc.IJC_1371_21
Zhuo-Yin Wang, Jing-Tao Wang, Rui-Xin Li, Guo-Jun Wang, Bu-Lang Gao

Background: This study was conducted to investigate the clinical and pathological characteristics of patients with pregnancy-associated gastric cancer.

Materials and methods: A retrospective study was performed on nine patients with pregnancy-associated gastric cancer. The clinical data were analyzed.

Results: The main symptoms were nausea and vomiting (four cases), epigastric pain (two cases), and chest tightness/abdominal distension (two cases). CA19-9 was increased in six patients of whom five patients showed increased carcinoembryonic antigen (CEA) . The histological types were mainly poorly differentiated adenocarcinoma (five cases) and signet ring cell carcinoma (four cases). The most common metastasis sites were peritoneum (four cases) and ovary (three cases). One case was human epidermal growth factor receptor 2 (HER2) positive. Only three patients underwent radical resection, followed by chemotherapy (oxaliplatin plus S-1 [SOX]). Six patients with advanced cancer were mainly treated with oxaliplatin plus paclitaxel or SOX. After treatment, eight patients were followed up for 1-16 (mean 8.3) months. At 12-14 (mean 12.8) months after treatment, four patients were still alive (44.4%), including three cases of radical gastrectomy and one case with abdominal metastasis. Four patients died 1, 3, 4, and 16 months after diagnosis. Six newborn infants survived without tumor metastasis.

Conclusion: Pregnancy-associated gastric cancers are usually of poor differentiation and high malignancy and may present without specific clinical symptoms. CEA and CA19-9 can be used to assist the diagnosis of gastric cancer during pregnancy. Gestational age, pathological type, stage, and patient's wishes should be considered in planning treatment to maximize the benefits of mother and fetus.

背景:本研究旨在探讨妊娠相关胃癌患者的临床和病理特点。材料与方法:对9例妊娠相关性胃癌患者进行回顾性研究。对临床资料进行分析。结果:主要症状为恶心呕吐4例,上腹痛2例,胸闷/腹胀2例。6例患者CA19-9升高,5例患者癌胚抗原(CEA)升高。组织学类型以低分化腺癌(5例)和印戒细胞癌(4例)为主。最常见的转移部位为腹膜(4例)和卵巢(3例)。1例人表皮生长因子受体2 (HER2)阳性。只有3例患者行根治性切除,随后化疗(奥沙利铂+ S-1 [SOX])。6例晚期癌症患者主要采用奥沙利铂联合紫杉醇或SOX治疗。8例患者治疗后随访1 ~ 16个月,平均8.3个月。治疗后12-14个月(平均12.8个月),4例患者仍存活(44.4%),其中3例根治性胃切除术,1例腹部转移。4例患者在诊断后1、3、4和16个月死亡。6例新生儿存活,无肿瘤转移。结论:妊娠相关胃癌多为分化差、恶性程度高的胃癌,可能无特异性临床症状。CEA和CA19-9可用于妊娠期胃癌的辅助诊断。在计划治疗时应考虑胎龄、病理类型、分期和患者的意愿,以最大限度地提高母亲和胎儿的利益。
{"title":"Clinical and pathological characteristics and treatment of gastric cancer during pregnancy.","authors":"Zhuo-Yin Wang, Jing-Tao Wang, Rui-Xin Li, Guo-Jun Wang, Bu-Lang Gao","doi":"10.4103/ijc.IJC_1371_21","DOIUrl":"10.4103/ijc.IJC_1371_21","url":null,"abstract":"<p><strong>Background: </strong>This study was conducted to investigate the clinical and pathological characteristics of patients with pregnancy-associated gastric cancer.</p><p><strong>Materials and methods: </strong>A retrospective study was performed on nine patients with pregnancy-associated gastric cancer. The clinical data were analyzed.</p><p><strong>Results: </strong>The main symptoms were nausea and vomiting (four cases), epigastric pain (two cases), and chest tightness/abdominal distension (two cases). CA19-9 was increased in six patients of whom five patients showed increased carcinoembryonic antigen (CEA) . The histological types were mainly poorly differentiated adenocarcinoma (five cases) and signet ring cell carcinoma (four cases). The most common metastasis sites were peritoneum (four cases) and ovary (three cases). One case was human epidermal growth factor receptor 2 (HER2) positive. Only three patients underwent radical resection, followed by chemotherapy (oxaliplatin plus S-1 [SOX]). Six patients with advanced cancer were mainly treated with oxaliplatin plus paclitaxel or SOX. After treatment, eight patients were followed up for 1-16 (mean 8.3) months. At 12-14 (mean 12.8) months after treatment, four patients were still alive (44.4%), including three cases of radical gastrectomy and one case with abdominal metastasis. Four patients died 1, 3, 4, and 16 months after diagnosis. Six newborn infants survived without tumor metastasis.</p><p><strong>Conclusion: </strong>Pregnancy-associated gastric cancers are usually of poor differentiation and high malignancy and may present without specific clinical symptoms. CEA and CA19-9 can be used to assist the diagnosis of gastric cancer during pregnancy. Gestational age, pathological type, stage, and patient's wishes should be considered in planning treatment to maximize the benefits of mother and fetus.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 1","pages":"82-88"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144077538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prognostic role of omental, ovarian chemotherapy response score and CA125 in predicting survival in patients with tubo-ovarian high-grade serous carcinoma/primary peritoneal carcinoma receiving neoadjuvant chemotherapy. 网膜、卵巢化疗反应评分和CA125在预测输卵管卵巢高级别浆液性癌/原发性腹膜癌接受新辅助化疗患者生存中的预后作用
IF 0.9 4区 医学 Q4 ONCOLOGY Pub Date : 2025-01-01 Epub Date: 2025-05-16 DOI: 10.4103/ijc.ijc_894_21
Ramya D Ravi, Kiran A Kulkarni, Geeta Acharya, Premalatha Siddharta, Gayatri Ravikumar, Vishakha C Bidkar, D Mohanapriya

Objective: To assess the role of omental and ovarian chemotherapy response score (CRS) and CA125 as a predictor of prognosis in patients with tubo-ovarian high-grade serous carcinoma (HGSC)/primary peritoneal carcinoma (PPC) receiving neoadjuvant chemotherapy (NACT). In addition, to study the correlation of omental CRS with chemoresistance.

Methods: A retrospective record review of patients with tubo-ovarian HGSC/PPC receiving NACT followed by interval debulking surgery (IDS) between January 2012 and May 2020 was done. The slides of the omentum and ovarian tissue of the patients were retrieved and reviewed by a trained pathologist. During analysis, CRS 1 and CRS 2 were merged together for comparison against CRS 3.

Results: A total of 44 patients with a mean age of 54 years were included in the study. Among the patients, 29.5%, 38.6%, and 31.8% had a CRS of 1, 2, and 3, respectively, on the omental specimen and 31.8%, 43.2%, and 25% on the ovarian specimen. Median PFS and OS was significantly better with omental CRS 3 (P = < 0.0001 and P = < 0.00065). No significant difference in median OS of patients was noted with ovarian CRS 1, 2, or 3 (P = 0.057); however, the median PFS was significantly better in patients with CRS 3 on ovarian tissue (P = 0.036). Platinum resistance was significantly lower in patients with CRS 3 on omentum (P = 0.001). The value of CA125 post NACT had a significant association with PFS on both univariate and multivariate analyses. There was no statistically significant correlation between CA125 and omental CRS.

Conclusion: Omental CRS has a prognostic significance for patients with tubo-ovarian HGSC/PPC receiving NACT and correlates significantly with PFS and OS. Ovarian CRS correlates significantly only with PFS. Post NACT CA125 value had a significant association with PFS.

目的:评价大网膜和卵巢化疗反应评分(CRS)和CA125在输卵管卵巢高级别浆液性癌(HGSC)/原发性腹膜癌(PPC)接受新辅助化疗(NACT)患者预后中的作用。此外,研究大网膜CRS与化疗耐药的相关性。方法:回顾性分析2012年1月至2020年5月期间输卵管卵巢HGSC/PPC患者接受NACT后进行间歇减体积手术(IDS)的记录。患者的网膜和卵巢组织的载玻片由训练有素的病理学家检索和审查。分析时,将CRS 1和CRS 2合并,与CRS 3进行比较。结果:共纳入44例患者,平均年龄54岁。其中,29.5%、38.6%、31.8%的患者网膜标本的CRS分别为1、2、3,卵巢标本的CRS分别为31.8%、43.2%、25%。中位PFS和OS显著优于网膜CRS 3 (P = < 0.0001和P = < 0.00065)。卵巢CRS为1、2或3的患者中位OS无显著差异(P = 0.057);然而,CRS为3的卵巢组织患者的中位PFS明显更好(P = 0.036)。网膜CRS 3组患者的铂耐药性显著降低(P = 0.001)。在单因素和多因素分析中,NACT后CA125值与PFS均有显著相关性。CA125与网膜CRS的相关性无统计学意义。结论:大网膜CRS对输卵管卵巢HGSC/PPC接受NACT治疗的患者具有预后意义,并与PFS和OS显著相关。卵巢CRS仅与PFS显著相关。NACT后CA125值与PFS有显著相关性。
{"title":"The prognostic role of omental, ovarian chemotherapy response score and CA125 in predicting survival in patients with tubo-ovarian high-grade serous carcinoma/primary peritoneal carcinoma receiving neoadjuvant chemotherapy.","authors":"Ramya D Ravi, Kiran A Kulkarni, Geeta Acharya, Premalatha Siddharta, Gayatri Ravikumar, Vishakha C Bidkar, D Mohanapriya","doi":"10.4103/ijc.ijc_894_21","DOIUrl":"10.4103/ijc.ijc_894_21","url":null,"abstract":"<p><strong>Objective: </strong>To assess the role of omental and ovarian chemotherapy response score (CRS) and CA125 as a predictor of prognosis in patients with tubo-ovarian high-grade serous carcinoma (HGSC)/primary peritoneal carcinoma (PPC) receiving neoadjuvant chemotherapy (NACT). In addition, to study the correlation of omental CRS with chemoresistance.</p><p><strong>Methods: </strong>A retrospective record review of patients with tubo-ovarian HGSC/PPC receiving NACT followed by interval debulking surgery (IDS) between January 2012 and May 2020 was done. The slides of the omentum and ovarian tissue of the patients were retrieved and reviewed by a trained pathologist. During analysis, CRS 1 and CRS 2 were merged together for comparison against CRS 3.</p><p><strong>Results: </strong>A total of 44 patients with a mean age of 54 years were included in the study. Among the patients, 29.5%, 38.6%, and 31.8% had a CRS of 1, 2, and 3, respectively, on the omental specimen and 31.8%, 43.2%, and 25% on the ovarian specimen. Median PFS and OS was significantly better with omental CRS 3 (P = < 0.0001 and P = < 0.00065). No significant difference in median OS of patients was noted with ovarian CRS 1, 2, or 3 (P = 0.057); however, the median PFS was significantly better in patients with CRS 3 on ovarian tissue (P = 0.036). Platinum resistance was significantly lower in patients with CRS 3 on omentum (P = 0.001). The value of CA125 post NACT had a significant association with PFS on both univariate and multivariate analyses. There was no statistically significant correlation between CA125 and omental CRS.</p><p><strong>Conclusion: </strong>Omental CRS has a prognostic significance for patients with tubo-ovarian HGSC/PPC receiving NACT and correlates significantly with PFS and OS. Ovarian CRS correlates significantly only with PFS. Post NACT CA125 value had a significant association with PFS.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 1","pages":"17-22"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144078022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adult pineoblastoma: A prospective study and twelve-year experience from three tertiary care cancer institutes of India depicting the effect of various independent parameters and therapeutic strategy on progression and survival in this extremely rare malignancy. 成人松果体母细胞瘤:一项前瞻性研究和印度三家三级护理癌症研究所12年的经验,描述了各种独立参数和治疗策略对这种极其罕见的恶性肿瘤的进展和生存的影响。
IF 0.9 4区 医学 Q4 ONCOLOGY Pub Date : 2025-01-01 Epub Date: 2025-05-16 DOI: 10.4103/ijc.ijc_1164_21
Abhishek Purkayastha, Neelam Sharma, Sachin Taneja, Virender Suhag, Saurabh Bobdey

Background: Pineoblastomas are highly aggressive malignant grade-IV tumors of embryonal origin with poor prognosis, accounting for < 0.1% of all brain tumors, affecting mainly the pediatric and adolescent cases but extremely rare in adults with an incidence of 0.1%-<1%. With scarce Indian and world data involving adult patients due to its rarity and lack of large prospective cohorts, this study was undertaken to determine survival outcomes in adult cases undergoing surgery, postoperative radiation therapy, and chemotherapy in terms of clinical response, prognosis, and disease progression.

Methods: Intake, treatment, and follow-up of patients were done from July 2009 to July 2021. A total of 1085 cases of primary brain tumors comprising malignant and benign adult and pediatric patients were registered over the study period. Adult pineoblastomas constituted 10/1085 (0.9%) cases of all primary brain tumors. All eligible patients underwent surgery, postoperative radiation therapy with concurrent chemotherapy, followed by adjuvant chemotherapy. Univariate Cox regression analysis was used to identify possible prognostic factors. Kaplan-Meier survival analysis was performed to estimate survival.

Results: The median disease-free survival was 63 months, and the median overall survival was 83 months. Poor performance status (P = 0.043), greater presenting symptoms (P = 0.041), and presence of residual disease (P = 0.000) were identified as independent predictors of reduced disease-free survival, without affecting overall survival.

Conclusion: We undertook this study keeping the dose of postoperative radiation therapy and chemotherapy regimens constant for all patients irrespective of surgical status to maintain uniformity in the survival quotient. Despite the limitations, this study may represent the largest analysis of adult pineoblastomas reported in Indian literature to date.

背景:松果母细胞瘤是胚胎起源的高度侵袭性恶性iv级肿瘤,预后差,占所有脑肿瘤的< 0.1%,主要影响儿童和青少年,成人极为罕见,发病率为0.1%。方法:2009年7月至2021年7月对患者进行摄入、治疗和随访。在研究期间共登记了1085例原发性脑肿瘤,包括恶性和良性的成人和儿童患者。成人松果体母细胞瘤占所有原发性脑肿瘤的10/1085例(0.9%)。所有符合条件的患者均接受手术、术后放射治疗联合化疗以及辅助化疗。采用单因素Cox回归分析确定可能的预后因素。Kaplan-Meier生存分析估计生存率。结果:中位无病生存期为63个月,中位总生存期为83个月。表现不佳(P = 0.043)、更严重的症状(P = 0.041)和残留疾病的存在(P = 0.000)被确定为无病生存降低的独立预测因素,但不影响总生存。结论:在本研究中,我们保持所有患者的术后放疗和化疗剂量不变,而不考虑手术状态,以保持生存商的一致性。尽管有局限性,这项研究可能是迄今为止印度文献中报道的最大的成人松果体母细胞瘤分析。
{"title":"Adult pineoblastoma: A prospective study and twelve-year experience from three tertiary care cancer institutes of India depicting the effect of various independent parameters and therapeutic strategy on progression and survival in this extremely rare malignancy.","authors":"Abhishek Purkayastha, Neelam Sharma, Sachin Taneja, Virender Suhag, Saurabh Bobdey","doi":"10.4103/ijc.ijc_1164_21","DOIUrl":"10.4103/ijc.ijc_1164_21","url":null,"abstract":"<p><strong>Background: </strong>Pineoblastomas are highly aggressive malignant grade-IV tumors of embryonal origin with poor prognosis, accounting for < 0.1% of all brain tumors, affecting mainly the pediatric and adolescent cases but extremely rare in adults with an incidence of 0.1%-<1%. With scarce Indian and world data involving adult patients due to its rarity and lack of large prospective cohorts, this study was undertaken to determine survival outcomes in adult cases undergoing surgery, postoperative radiation therapy, and chemotherapy in terms of clinical response, prognosis, and disease progression.</p><p><strong>Methods: </strong>Intake, treatment, and follow-up of patients were done from July 2009 to July 2021. A total of 1085 cases of primary brain tumors comprising malignant and benign adult and pediatric patients were registered over the study period. Adult pineoblastomas constituted 10/1085 (0.9%) cases of all primary brain tumors. All eligible patients underwent surgery, postoperative radiation therapy with concurrent chemotherapy, followed by adjuvant chemotherapy. Univariate Cox regression analysis was used to identify possible prognostic factors. Kaplan-Meier survival analysis was performed to estimate survival.</p><p><strong>Results: </strong>The median disease-free survival was 63 months, and the median overall survival was 83 months. Poor performance status (P = 0.043), greater presenting symptoms (P = 0.041), and presence of residual disease (P = 0.000) were identified as independent predictors of reduced disease-free survival, without affecting overall survival.</p><p><strong>Conclusion: </strong>We undertook this study keeping the dose of postoperative radiation therapy and chemotherapy regimens constant for all patients irrespective of surgical status to maintain uniformity in the survival quotient. Despite the limitations, this study may represent the largest analysis of adult pineoblastomas reported in Indian literature to date.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 1","pages":"64-75"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144077010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting pulmonary complications after esophagectomy: A retrospective cohort study. 预测食管切除术后肺部并发症:一项回顾性队列研究。
IF 0.9 4区 医学 Q4 ONCOLOGY Pub Date : 2025-01-01 Epub Date: 2025-05-16 DOI: 10.4103/ijc.ijc_67_22
Priya Ranganathan, Sabita Jiwnani, Apurva Ashok, Pallavi Purwar, George Karimundackal, Swapnil Parab, Madhavi Shetmahajan, Conjeevaram S Pramesh

Background: Pulmonary complications are the main cause of postoperative mortality in patients undergoing esophagectomy. The aim of this study was to identify the risk factors associated with major pulmonary complications in these patients.

Methods: This was a retrospective cohort study of patients who underwent esophagectomy between January 2004 and December 2014. We retrieved data on patient- and surgery-related variables and the postoperative complications from medical records, including age, gender, physical status as per the American Society of Anesthesiologists' (ASA) classification, smoking status, hemoglobin, albumin, creatinine, forced expiratory volume in the first second (FEV1), neoadjuvant therapy, type of surgery (transthoracic vs. others), thoracic approach (minimally invasive vs. open), lymphadenectomy type (three field or abdominal vs. two field), intraoperative blood loss, operative time, and use of epidural analgesia. We classified pulmonary complications using the Clavien-Dindo system. Multivariable logistic regression analysis was used to derive the odds ratios (OR) with 95% confidence intervals (CI) to identify significant risk factors for major pulmonary complications (Clavien-Dindo grade 3 or more).

Results: We obtained relevant data on 1189 patients operated during the study period. Increasing age (OR 1.03, 95% CI 1.01; 1.04; P < 0.01), FEV1% less than 70% (OR 1.71, 95% CI 1.03; 2.83; P = 0.04), three-field lymphadenectomy (OR 2.12, 95% CI 1.50; 3.01; P < 0.01), and use of analgesia techniques other than epidural (OR 1.51, 95% CI 1.07; 2.13; P = 0.02) were independent predictors of major pulmonary complications.

Conclusions: The recognition of factors associated with increased risk of pulmonary complications in patients undergoing esophagectomy could help in risk stratification, preoperative optimization, and early detection of complications.

背景:肺并发症是食管切除术患者术后死亡的主要原因。本研究的目的是确定与这些患者主要肺部并发症相关的危险因素。方法:这是一项回顾性队列研究,研究对象是2004年1月至2014年12月期间接受食管切除术的患者。我们从医疗记录中检索了患者和手术相关变量以及术后并发症的数据,包括年龄、性别、按照美国麻醉医师协会(ASA)分类的身体状况、吸烟状况、血红蛋白、白蛋白、肌酐、第一秒用力呼气量(FEV1)、新辅助治疗、手术类型(经胸手术还是其他手术)、胸部入路(微创手术还是开放手术)、淋巴结切除类型(三场或腹部vs.两场),术中出血量,手术时间,硬膜外镇痛的使用。我们使用Clavien-Dindo系统对肺部并发症进行分类。采用多变量logistic回归分析,得出95%可信区间(CI)的比值比(OR),以确定主要肺部并发症(Clavien-Dindo 3级或以上)的重要危险因素。结果:我们获得了研究期间1189例手术患者的相关资料。年龄增加(OR 1.03, 95% CI 1.01;1.04;P < 0.01), FEV1%小于70% (OR 1.71, 95% CI 1.03;2.83;P = 0.04),三野淋巴结切除术(OR 2.12, 95% CI 1.50;3.01;P < 0.01),以及使用硬膜外镇痛技术(OR 1.51, 95% CI 1.07;2.13;P = 0.02)是主要肺部并发症的独立预测因子。结论:识别食管切除术患者肺部并发症风险增加的相关因素有助于风险分层、术前优化和早期发现并发症。
{"title":"Predicting pulmonary complications after esophagectomy: A retrospective cohort study.","authors":"Priya Ranganathan, Sabita Jiwnani, Apurva Ashok, Pallavi Purwar, George Karimundackal, Swapnil Parab, Madhavi Shetmahajan, Conjeevaram S Pramesh","doi":"10.4103/ijc.ijc_67_22","DOIUrl":"10.4103/ijc.ijc_67_22","url":null,"abstract":"<p><strong>Background: </strong>Pulmonary complications are the main cause of postoperative mortality in patients undergoing esophagectomy. The aim of this study was to identify the risk factors associated with major pulmonary complications in these patients.</p><p><strong>Methods: </strong>This was a retrospective cohort study of patients who underwent esophagectomy between January 2004 and December 2014. We retrieved data on patient- and surgery-related variables and the postoperative complications from medical records, including age, gender, physical status as per the American Society of Anesthesiologists' (ASA) classification, smoking status, hemoglobin, albumin, creatinine, forced expiratory volume in the first second (FEV1), neoadjuvant therapy, type of surgery (transthoracic vs. others), thoracic approach (minimally invasive vs. open), lymphadenectomy type (three field or abdominal vs. two field), intraoperative blood loss, operative time, and use of epidural analgesia. We classified pulmonary complications using the Clavien-Dindo system. Multivariable logistic regression analysis was used to derive the odds ratios (OR) with 95% confidence intervals (CI) to identify significant risk factors for major pulmonary complications (Clavien-Dindo grade 3 or more).</p><p><strong>Results: </strong>We obtained relevant data on 1189 patients operated during the study period. Increasing age (OR 1.03, 95% CI 1.01; 1.04; P < 0.01), FEV1% less than 70% (OR 1.71, 95% CI 1.03; 2.83; P = 0.04), three-field lymphadenectomy (OR 2.12, 95% CI 1.50; 3.01; P < 0.01), and use of analgesia techniques other than epidural (OR 1.51, 95% CI 1.07; 2.13; P = 0.02) were independent predictors of major pulmonary complications.</p><p><strong>Conclusions: </strong>The recognition of factors associated with increased risk of pulmonary complications in patients undergoing esophagectomy could help in risk stratification, preoperative optimization, and early detection of complications.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 1","pages":"135-141"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144077768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian journal of cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1